Summary
Medtronic plc (MDT) filed an 8-K on November 21, 2023, to announce its second quarter fiscal year 2024 financial results. The primary purpose of this filing is to furnish the press release detailing these results, which were issued on the same date. Investors should review the furnished press release for comprehensive details on the company's performance during the quarter, including revenue, earnings, and any significant business updates or segment performance. This 8-K serves as the official notification of these results to the market.
Key Highlights
- 1Medtronic plc announced its second quarter fiscal year 2024 financial results via a press release dated November 21, 2023.
- 2The 8-K filing's primary purpose is to furnish this press release to the SEC.
- 3Investors can find detailed financial performance information, including revenue and earnings, within the press release.
- 4The filing confirms the reporting of Q2 FY24 results as per standard SEC disclosure requirements.
- 5Exhibit 99.1 contains the full press release, which is the core document for analyzing the quarter's performance.
Frequently Asked Questions
The 8-K filing itself does not contain the specific financial results. Investors need to refer to the press release furnished as Exhibit 99.1 for detailed information on revenue, earnings per share, segment performance, and other key financial metrics for Q2 FY24.
The detailed financial results are provided in the press release dated November 21, 2023, which is attached as Exhibit 99.1 to this 8-K filing. Investors should consult this document for comprehensive information.
This 8-K filing formally announces Medtronic's Q2 FY24 financial results to the public and the SEC. It serves as an official record and directs investors to the accompanying press release for the specifics of the company's operational and financial performance during the quarter.